- Corange Ltd.
- Bergen Brunswig Corp.
- Cardinal Health Inc.
- Boston Scientific Corp.
- St. Jude Medical Inc.
- Guidant Corp.
- Medtronic PLC
- Mallinckrodt PLC
- Bristol-Myers Squibb Co.
- Johnson & Johnson
- Imagyn Medical Technologies Inc.
- Boehringer Mannheim GmbH
- Beckman Coulter Inc.
- Abbott Laboratories Inc.
- Bio-Rad Pasteur
- Target Therapeutics Inc.
- Ventritex Inc.
- Daig Corp.
- EndoVascular Technologies Inc.
- DePuy Synthes
- Pfizer Inc.
- Stryker Orthopaedics
- Aksys Ltd.
- Cardiac Pathways Corp.
- CardioGenesis Corp.
- CardioThoracic Systems Inc.
- Conceptus Inc.
- FemRx Inc.
- BOC Group PLC
- Cortech Inc.
- Medarex Inc.
- GenPharm International Inc.
- Immunex Corp.
- Genentech Inc.
- Amgen Inc.
- Synergen Inc.
- Genzyme Corp.
- Accelrys Inc.
- Molecular Simulations Inc.
- Corning Inc.
- Novartis AG
- Schering AG
- Schwarz Pharma AG
- Merck KGaA
- Boehringer Ingelheim GmbH
- Warner-Lambert Co.
- GD Searle & Co.
- Schering-Plough Corp.
- Monsanto Co.
- RP Scherer Corp.
- Diversified Pharmaceutical Services Inc.
- CymaBay Therapeutics Inc.
- Takeda Oncology
- Millennium BioTherapeutics Inc.
- Vernalis Group PLC
- SmithKline/Glaxo merger plans fall through
- Tyco's Kendall division acquires AHP's Sherwood-Davis
- Urohealth acquires Imagyn for $65mm in stock
- Beckman Instruments to acquire Coulter for $875mm in cash
- Abbott buys International Murex
- Boston Scientific buys SciMed Life Systems in stock swap
- St. Jude acquires Ventritex for $505mm in stock
- St. Jude acquires Daig for $427 million
- Nellcor acquires Puritan-Bennett in $475 mm stock swap
- Sulzer Medica nets $521mm in global IPO
- DePuy acquires spinal implant maker AcroMed
- BOC Group to sell its Ohmeda health care division
- Agouron acquires Alanex for approximately $64mm
- Amgen to acquire Synergen for $239.6 million
- Pharmacopeia will buy Molecular Simulations for stock
- Arris acquires Sequana Therapeutics in a $166mm stock swap
- Pfizer co-promotes Searle's Cox-2 inhibitor
- Schering-Plough licenses rights to Sepracor patents
- SmithKline acquires Diversified Pharmaceutical Services
- Abbott's Ross Labs and Metabolex co-develop nutritionals
- Metabolex completes $29.5mm private placement
- Lilly and Millennium biotherapeutic division develop proteins
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.